The primary mission of the Boston University Alzheimer's Disease Center (BU ADC) Data Management and Statistics Core (DMSC) is to provide leadership and expertise in all phases of data management and statistical analyses, from research project development to publication of results. This collaborative assistance encompasses analytic plan development, database design, implementation of quality control procedures, technical support, creation of analytic datasets, statistical analyses, and manuscript preparation. DMSC faculty and staff maintain ongoing communication and interactions in collaborative relationship with members of all other BU ADC Cores and projects as well as the National Alzheimer's Coordinating Center (NACC). To continue accomplishing these goals into the next funding cycle, the DSMC will continue to leverage DMSC resources, including state-of-the-art hardware, software and expertise, to enable the appropriate management and analysis of data resulting from BU ADC.
The specific aims of the DMSC are:
Specific Aim 1. Provide data system expertise, assistance, and an enhanced infrastructure, including hardware, software, networks, and procedures, to ensure data security and integrity across the BU ADC.
Specific Aim 2. Provide expertise and assistance in developing and updating existing data systems for data collection, participant and data tracking, data management, and quality control procedures for BU ADC activities, including the Uniform Data Set (UDS), neuropathology, NACC, and requests from local Investigators. Maintain and expand training of all BU ADC faculty and staff in use of data systems through written materials and in-person and web-based training sessions.
Specific Aim 3. Continue to support and manage BU ADC data and resource sharing with NACC and local BU investigators. This support includes the transmittal of raw UDS and Neuropathology data to NACC as well as creation of analytic datasets, including calculated variables, for specific, approved analyses;and support and management of all resource requests, including data, participants, tissue, and animals.
Specific Aim 4. Provide high-level data management and biostatistical expertise, support and consulting to BU ADC investigators and new BU ADC-affiliated proposals and pilot grant projects, including study design, implementation and interpretation of data analyses, preparation of funding applications, and manuscript development.

Public Health Relevance

Providing the BU ADC with state of the art data management systems, and procedures and training in the use of those sytsems and procedures will ensure that only the highest quality data will be used in all BU ADC research. Advising on appropriate study design methodology and analytic techniques and providing analytic support and statistical programming will ultimate ensure the scientific integrity of research findings.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Boston University
United States
Zip Code
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Li, Dan; Wang, Lei; Maziuk, Brandon F et al. (2018) Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau. J Biol Chem 293:12081-12094
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Tagge, Chad A; Fisher, Andrew M; Minaeva, Olga V et al. (2018) Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model. Brain 141:422-458
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Chung, Jaeyoon; Wang, Xulong; Maruyama, Toru et al. (2018) Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages. Alzheimers Dement 14:623-633
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826

Showing the most recent 10 out of 791 publications